Peptide TherapeuticsPeer Reviewed
Thrombolysis Alone vs With Argatroban or Eptifibatide: A Prespecified Subgroup Analysis of the MOST Trial.
Authors (17)
Akash RoyDepartment of Public Health Sciences, Medical University of South Carolina, Charleston.
Jordan ElmDepartment of Public Health Sciences, Medical University of South Carolina, Charleston.
James R InglesDepartment of Public Health Sciences, Medical University of South Carolina, Charleston.
Noor SabaghaDepartment of Pharmacy, University of Cincinnati Medical Center, OH.
Neurology
Unknown
Published
Oct 13, 2025
Abstract
Abstract not available - data parsing issue resolved
Keywords
HumansPipecolic AcidsEptifibatideMaleFemaleArginineSulfonamidesAgedMiddle AgedIschemic StrokeThrombolytic TherapyPlatelet Aggregation InhibitorsSingle-Blind MethodFibrinolytic AgentsTreatment OutcomeTissue Plasminogen ActivatorDrug Therapy, Combination
Article Metrics
Sourcepubmed
Related Research
Explore more articles in this research category to discover related studies and findings.